Science Explorer Back to mapMap
Discussion
Researcher · Lead Discovery Center (Germany) · Germany

Carsten Schultz‐Fademrecht

Carsten Schultz‐Fademrecht publishes mostly in Molecular Biology, Organic Chemistry and Oncology, on topics such as Lung Cancer Treatments and Mutations, Cancer therapeutics and mechanisms and Protein Degradation and Inhibitors.

OpenAlex
World rank
#1,214,560
of 7,710,434 ranked researchers
Rank in Germany
#59,805
of 364,343
Works
59
Citations
2.5k
Citations per work
42.4
h-index
24
i10-index 35Top 24% in Molecular Biology
Carsten Schultz‐Fademrecht

What does Carsten Schultz‐Fademrecht research?

Carsten Schultz‐Fademrecht's work is mostly in Biochemistry, Genetics and Molecular Biology (34%), Medicine (30%), Chemistry (22%).

Life Sciences: 22 works · 37.0% of their workBiochemistry, Genetics and Molecular Biology: 20 works · 33.6% of their workMolecular Biology: 20 works · 33.6% of their workImmunology and Microbiology: 2 works · 3.4% of their workImmunology: 2 works · 3.4% of their workHealth Sciences: 18 works · 30.2% of their workMedicine: 18 works · 30.2% of their workOncology: 11 works · 18.8% of their workPulmonary and Respiratory Medicine: 5 works · 8.7% of their workGenetics: 2 works · 2.7% of their workPhysical Sciences: 13 works · 22.1% of their workChemistry: 13 works · 22.1% of their workOrganic Chemistry: 13 works · 22.1% of their workEverything else: 6 works · 10.7% of their workTHEIR WORKCarstenSchultz‐Fademrecht59works
Life Sciences37%Physical Sciences22%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2033.6%
    2. Immunology and Microbiology23.4%
    1. Medicine1830.2%
    1. Chemistry1322.1%
  4. Everything else610.7%
  1. 1Molecular Biology34% of their works
  2. 2Organic Chemistry22% of their works
  3. 3Oncology19% of their works
  4. 4Pulmonary and Respiratory Medicine9% of their works
  5. 5Immunology3% of their works
  6. 6Genetics3% of their works

Research topics

Which keywords describe Carsten Schultz‐Fademrecht's research?

The keywords of their largest research topics: Cancer Therapy, Chemotherapy, Transcriptional Regulation, EGFR Mutations, Targeted Therapy, DNA, Topoisomerases and BET Bromodomains.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer Therapy224 topics
  2. Chemotherapy132 topics
  3. Transcriptional Regulation112 topics
  4. EGFR Mutations81 topic
  5. Targeted Therapy81 topic
  6. DNA71 topic
  7. Topoisomerases71 topic
  8. BET Bromodomains61 topic
  9. Breast Cancer61 topic
  10. Cell Cycle61 topic
  11. Fibroblast Activation Protein61 topic
  12. HER261 topic
  13. PROTACs61 topic
  14. Tumor Microenvironment61 topic
  15. p5361 topic
  16. HDAC Inhibitors51 topic
  17. Histone Deacetylases51 topic
  18. Protein Kinases51 topic
  19. Ras Signaling51 topic

Where does Carsten Schultz‐Fademrecht work?

Carsten Schultz‐Fademrecht's main affiliation in the publication record is Lead Discovery Center (Germany), Germany.

How many publications and citations does Carsten Schultz‐Fademrecht have?

OpenAlex counts 59 works and 2,503 citations for Carsten Schultz‐Fademrecht, an h-index of 24, ranking #1,214,560 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Carsten Schultz‐Fademrecht. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.